VTv Therapeutics Earnings Estimate

VTVT Stock  USD 22.16  0.58  2.55%   
The next projected EPS of VTv Therapeutics is estimated to be -0.9125 with future projections ranging from a low of -0.9125 to a high of -0.9125. VTv Therapeutics' most recent 12-month trailing earnings per share (EPS TTM) is at -4.37. Please be aware that the consensus of earnings estimates for vTv Therapeutics is based on EPS before non-recurring items and includes expenses related to employee stock options.
 
Yuan Drop
 
Covid
VTv Therapeutics is projected to generate -0.9125 in earnings per share on the 31st of December 2024. VTv Therapeutics earnings estimates show analyst consensus about projected vTv Therapeutics EPS (Earning Per Share). It derives the highest and the lowest estimates based on VTv Therapeutics' historical volatility. Many public companies, such as VTv Therapeutics, manage the perception of their earnings on a regular basis to make sure that analyst estimates are accurate. Future earnings calculations are also an essential input when attempting to value a firm. By analyzing VTv Therapeutics' earnings estimates, investors can diagnose different trends across VTv Therapeutics' analyst sentiment over time as well as compare current estimates against different timeframes. Gross Profit Margin is likely to gain to 0.90 in 2025, whereas Gross Profit is likely to drop (16.4 M) in 2025.
  
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in vTv Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real.
For more information on how to buy VTv Stock please use our How to Invest in VTv Therapeutics guide.

VTv Therapeutics Earnings Estimation Breakdown

The calculation of VTv Therapeutics' earning per share is based on the data from the past 12 consecutive months, used for reporting the company's financial figures. The next projected EPS of VTv Therapeutics is estimated to be -0.9125 with the future projection ranging from a low of -0.9125 to a high of -0.9125. Please be aware that this consensus of annual earnings estimates for vTv Therapeutics is based on EPS before non-recurring items and includes expenses related to employee stock options.
Last Reported EPS
-1.67
-0.91
Lowest
Expected EPS
-0.9125
-0.91
Highest

VTv Therapeutics Earnings Projection Consensus

Suppose the current estimates of VTv Therapeutics' value are higher than the current market price of the VTv Therapeutics stock. In this case, investors may conclude that VTv Therapeutics is overpriced and will exhibit bullish sentiment. On the other hand, if the present value is lower than the stock price, analysts may conclude that the market undervalues the equity. These scenarios may suggest that the market is not as efficient as it should be at the estimation time, and VTv Therapeutics' stock will quickly adjusts to the new information provided by the consensus estimate.
Number of AnalystsHistorical AccuracyLast Reported EPSEstimated EPS for 31st of December 2024Current EPS (TTM)
151.34%
-1.67
-0.9125
-4.37

VTv Therapeutics Earnings per Share Projection vs Actual

Actual Earning per Share of VTv Therapeutics refers to what the company shows during its earnings calls or quarterly reports. The Expected EPS is what analysts covering vTv Therapeutics predict the company's earnings will be in the future. The higher the earnings per share of VTv Therapeutics, the better is its profitability. While calculating the Earning per Share, we use the weighted ratio, as the number of shares outstanding can change over time.

VTv Therapeutics Estimated Months Earnings per Share

For an investor who is primarily interested in generating an income out of investing in entities such as VTv Therapeutics, the EPS ratio can tell if the company is intending to increase its current dividend. Although EPS is an essential tool for investors, it should not be used in isolation. EPS of VTv Therapeutics should always be considered in relation to other companies to make a more educated investment decision.

VTv Quarterly Analyst Estimates and Surprise Metrics

Earnings surprises can significantly impact VTv Therapeutics' stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2024-03-13
2023-12-31-0.07-1.67-1.62285 
2023-11-09
2023-09-30-0.08-3.2-3.123900 
2023-08-11
2023-06-30-0.07-0.070.0
2023-05-11
2023-03-31-0.09-0.060.0333 
2023-03-06
2022-12-31-0.06-0.060.0
2022-11-10
2022-09-30-0.04-0.05-0.0125 
2022-08-15
2022-06-30-0.09-0.040.0555 
2022-05-12
2022-03-31-0.08-0.1-0.0225 
2022-03-29
2021-12-31-0.07-0.11-0.0457 
2021-11-09
2021-09-30-0.07-0.020.0571 
2021-08-04
2021-06-30-0.07-0.010.0685 
2021-05-05
2021-03-31-0.06-0.08-0.0233 
2021-02-24
2020-12-31-0.050.020.07140 
2020-11-05
2020-09-30-0.09-0.030.0666 
2020-08-03
2020-06-30-0.09-0.070.0222 
2020-05-07
2020-03-31-0.1-0.11-0.0110 
2020-02-20
2019-12-31-0.09-0.13-0.0444 
2019-10-30
2019-09-30-0.11-0.13-0.0218 
2019-07-31
2019-06-30-0.1-0.10.0
2019-05-01
2019-03-31-0.24-0.090.1562 
2019-02-26
2018-12-31-0.11-0.15-0.0436 
2018-11-08
2018-09-30-0.12-0.060.0650 
2018-08-03
2018-06-30-0.25-0.31-0.0624 
2018-05-15
2018-03-31-0.34-0.30.0411 
2018-02-27
2017-12-31-0.42-0.44-0.02
2017-11-01
2017-09-30-0.4-0.380.02
2017-08-02
2017-06-30-0.43-0.410.02
2017-05-03
2017-03-31-0.44-0.440.0
2017-02-24
2016-12-31-0.28-0.42-0.1450 
2016-11-02
2016-09-30-0.46-0.410.0510 
2016-08-02
2016-06-30-0.85-0.470.3844 
2016-05-12
2016-03-31-0.96-0.420.5456 
2016-03-01
2015-12-31-1.26-0.350.9172 
2015-11-12
2015-09-30-1.17-1.18-0.01
2015-09-14
2015-06-30-1.03-1.12-0.09

About VTv Therapeutics Earnings Estimate

The earnings estimate module is a useful tool to check what professional financial analysts are assuming about the future of VTv Therapeutics earnings. We show available consensus EPS estimates for the upcoming years and quarters. Investors can also examine how these consensus opinions have evolved historically. We show current VTv Therapeutics estimates, future projections, as well as estimates 1, 2, and three years ago. Investors can search for a specific entity to conduct investment planning and build diversified portfolios. Please note, earnings estimates provided by Macroaxis are the average expectations of expert analysts that we track. If a given stock such as VTv Therapeutics fails to match professional earnings estimates, it usually performs purely. Wall Street refers to that as a 'negative surprise.' If a company 'beats' future estimates, it's usually called an 'upside surprise.'
Please read more on our stock advisor page.
Last ReportedProjected for Next Year
Retained Earnings-323.2 M-339.4 M
Retained Earnings Total Equity-239 M-250.9 M
Earnings Yield(0.97)(0.92)
Price Earnings Ratio(1.36)(1.43)
Price Earnings To Growth Ratio 0.05  0.05 

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for VTv Stock Analysis

When running VTv Therapeutics' price analysis, check to measure VTv Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy VTv Therapeutics is operating at the current time. Most of VTv Therapeutics' value examination focuses on studying past and present price action to predict the probability of VTv Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move VTv Therapeutics' price. Additionally, you may evaluate how the addition of VTv Therapeutics to your portfolios can decrease your overall portfolio volatility.